AA amyloidosis is a rare but serious complication of chronic inflammation that can affect the kidneys and other organs. This review summarizes its evolution in inflammatory joint diseases and the possible impact of modern treatments.

A novel hereditary AA amyloidosis caused by a SAA1 mutation reveals that AA amyloid can develop without inflammation, highlighting the need for genetic testing.

The epidemiology and clinical presentation of renal amyloidosis in Norway have changed substantially over the past 30 years, according to a nationwide study.

Study conducted in Jordan comparing the frequency of MEFV gene variants in 78 hemodialysis patients and 201 healthy controls. The M694V and V726A mutations are the most common in affected patients. Screening for these variants is essential for the early diagnosis of familial Mediterranean fever (FMF) and the prevention of AA amyloidosis.

This review summarizes the current state of research into the efficacy and safety of TCZ in Familial Mediterranean Fever (FMF).

Waldenström macroglobulinemia (WM) is a rare malignant hematopathy characterized by lymphoplasmacytic lymphoma (LPL) secreting IgM.

The authors report here the case of a 70-year-old man who received Atezolizumab as adjuvant therapy and developed nephrotic-like ...

This article reports the first case of iatrogenic systemic amyloidosis due to prolonged use of anakinra...